Antiepileptic drugs in developing countries

[1]  Anthony L. Johnson,et al.  Randomized controlled trial of phenobarbital for childhood epilepsy in rural India using broad outcome measures , 1998 .

[2]  G. Kaplanski,et al.  Ribavirin in hepatitis C related cryoglobulinemia. , 1998, The Journal of rheumatology.

[3]  R. Cooper,et al.  Disease burden in sub-Saharan Africa: what should we conclude in the absence of data? , 1998, The Lancet.

[4]  Anthony L. Johnson,et al.  Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India , 1998, The Lancet.

[5]  K. Tanikawa,et al.  High incidence of oral precancerous lesions in a hyperendemic area of hepatitis C virus infection , 1997 .

[6]  P Gaucher,et al.  Patient-to-patient transmission of hepatitis C virus during colonoscopy. , 1997, The New England journal of medicine.

[7]  A. Levey,et al.  Hepatitis C virus infection in dialysis and renal transplantation. , 1997, Kidney international.

[8]  K. Alberti,et al.  Diabetes Mellitus as a Cause of Death in Sub‐Saharan Africa: Results of a Community‐based Study in Tanzania , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[9]  G. Kaplanski,et al.  Extrahepatic Manifestations of Hepatitis C Virus Infection , 1996, Annals of Internal Medicine.

[10]  S. Kochen.  Costing of antiepileptic drugs , 1996, The Lancet.

[11]  M. Jadoul.  Transmission routes of HCV infection in dialysis. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  C. Carcassi,et al.  THE HLA‐DRB1*0101 ALLELE IS RESPONSIBLE FOR HLA SUSCEPTIBILITY TO LICHEN RUBER PLANUS , 1994, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[13]  J. Pawlotsky,et al.  Immunological disorders in C virus chronic active hepatitis: A prospective case‐control study , 1994, Hepatology.

[14]  F. Retornaz,et al.  Alpha interferon therapy in thrombocytopenia associated with hepatitis C virus infection. , 1994, Journal of hepatology.

[15]  S. Cunningham,et al.  Oral cancer development in patients with oral lichen planus. , 1993, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[16]  K. Alberti,et al.  Low prevalence of risk factors for coronary heart disease in rural Tanzania. , 1993, International journal of epidemiology.

[17]  Josemir W Sander,et al.  Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment , 1993, Epilepsy Research.

[18]  P. Bittencourt,et al.  Phenytoin and carbamazepine decrease oral bioavailability of praziquantel , 1992, Neurology.

[19]  J. W. A. S. Sander,et al.  Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya , 1991, The Lancet.

[20]  J. Molina-Font,et al.  Cognitive effects of long‐term treatment with phenobarbital and valproic acid in school children , 1990, Acta neurologica Scandinavica.

[21]  D. Hirtz,et al.  Phenobarbital for febrile seizures--effects on intelligence and on seizure recurrence. , 1990, The New England journal of medicine.

[22]  E. Vining,et al.  Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. , 1987, Pediatrics.